Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C BORDEN

Showing results (241-250 of 327) with videos related to

Pageof 33
Sort By:
Cancer Research|January 1, 1990
Modulation of interferon receptor expression during combination beta ser-interferon and gamma-interferon treatment of human colon carcinoma cellsJ H Schiller, S M Bushmeyer, F J Ruzicka, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|May 1, 1996
Hematologic and immunologic evaluation of recombinant human interleukin-6 in patients with advanced malignant disease: evidence for monocyte activationC A Keever-Taylor, P L Witt, R L Truitt, et al.
Cell Death and Differentiation|May 1, 2004
Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosisM Chawla-Sarkar, S I Bae, F J Reu, et al.
Cancer Biology & Therapy|May 21, 2014
Dual VEGF/VEGFR inhibition in advanced solid malignancies: clinical effects and pharmacodynamic biomarkersKriti Mittal, Henry Koon, Paul Elson, et al.
Journal of Surgical Oncology. Supplement|January 1, 1991
Applications of monoclonal antibodies and recombinant cytokines for the treatment of human colorectal and other carcinomasJ W Greiner, R V Smalley, E C Borden, et al.
Journal of Interferon Research|December 1, 1990
Biological and clinical effects of interferon-beta ser at two dosesE C Borden, J J Rinehart, B E Storer, et al.
Journal of Interferon Research|August 1, 1990
Basal and interferon-induced 2',5'-oligoadenylate synthetase in human monocytes, lymphocytes, and peritoneal macrophagesP L Witt, G T Spear, D O Helgeson, et al.
American Journal of Respiratory Cell and Molecular Biology|June 1, 1992
Effects of interferons beta or gamma on neopterin biosynthesis and tryptophan degradation by human alveolar macrophages in vitro: synergy with lipopolysaccharideK C Meyer, R Cornwell, J M Carlin, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|December 4, 2012
Thrombospondin-1 expression in melanoma is blocked by methylation and targeted reversal by 5-Aza-deoxycytidine suppresses angiogenesisDaniel J Lindner, Yan Wu, Rebecca Haney, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1982
Influence of non-specific immunologic factors on prognosis in advanced bronchogenic carcinomaA M Liberati, J G Voelkel, E C Borden, et al.
Pageof 33

Showing results (241-250 of 327) with videos related to

Sort By:
Pageof 33
Cancer Research|January 1, 1990
Modulation of interferon receptor expression during combination beta ser-interferon and gamma-interferon treatment of human colon carcinoma cellsJ H Schiller, S M Bushmeyer, F J Ruzicka, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|May 1, 1996
Hematologic and immunologic evaluation of recombinant human interleukin-6 in patients with advanced malignant disease: evidence for monocyte activationC A Keever-Taylor, P L Witt, R L Truitt, et al.
Cell Death and Differentiation|May 1, 2004
Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosisM Chawla-Sarkar, S I Bae, F J Reu, et al.
Cancer Biology & Therapy|May 21, 2014
Dual VEGF/VEGFR inhibition in advanced solid malignancies: clinical effects and pharmacodynamic biomarkersKriti Mittal, Henry Koon, Paul Elson, et al.
Journal of Surgical Oncology. Supplement|January 1, 1991
Applications of monoclonal antibodies and recombinant cytokines for the treatment of human colorectal and other carcinomasJ W Greiner, R V Smalley, E C Borden, et al.
Journal of Interferon Research|December 1, 1990
Biological and clinical effects of interferon-beta ser at two dosesE C Borden, J J Rinehart, B E Storer, et al.
Journal of Interferon Research|August 1, 1990
Basal and interferon-induced 2',5'-oligoadenylate synthetase in human monocytes, lymphocytes, and peritoneal macrophagesP L Witt, G T Spear, D O Helgeson, et al.
American Journal of Respiratory Cell and Molecular Biology|June 1, 1992
Effects of interferons beta or gamma on neopterin biosynthesis and tryptophan degradation by human alveolar macrophages in vitro: synergy with lipopolysaccharideK C Meyer, R Cornwell, J M Carlin, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|December 4, 2012
Thrombospondin-1 expression in melanoma is blocked by methylation and targeted reversal by 5-Aza-deoxycytidine suppresses angiogenesisDaniel J Lindner, Yan Wu, Rebecca Haney, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1982
Influence of non-specific immunologic factors on prognosis in advanced bronchogenic carcinomaA M Liberati, J G Voelkel, E C Borden, et al.
Pageof 33